| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 22 | 2023 | 125 | 2.530 |
Why?
|
| Obesity, Morbid | 19 | 2023 | 250 | 2.160 |
Why?
|
| Appendectomy | 10 | 2020 | 130 | 1.820 |
Why?
|
| General Surgery | 13 | 2024 | 344 | 1.790 |
Why?
|
| Esophageal Achalasia | 3 | 2019 | 39 | 1.640 |
Why?
|
| Appendicitis | 12 | 2018 | 176 | 1.570 |
Why?
|
| Laparoscopy | 19 | 2020 | 1288 | 1.330 |
Why?
|
| Audiovisual Aids | 2 | 2020 | 42 | 1.310 |
Why?
|
| Enterocolitis, Necrotizing | 13 | 2015 | 237 | 1.130 |
Why?
|
| Hernia, Inguinal | 4 | 2011 | 53 | 0.980 |
Why?
|
| Child | 92 | 2022 | 30357 | 0.970 |
Why?
|
| Infant | 70 | 2021 | 13889 | 0.960 |
Why?
|
| Adolescent | 94 | 2023 | 32464 | 0.910 |
Why?
|
| Bronchogenic Cyst | 2 | 2016 | 21 | 0.880 |
Why?
|
| Fundoplication | 4 | 2019 | 70 | 0.880 |
Why?
|
| Burnout, Professional | 6 | 2024 | 230 | 0.840 |
Why?
|
| Gastric Bypass | 9 | 2019 | 95 | 0.830 |
Why?
|
| Catheters, Indwelling | 4 | 2018 | 382 | 0.810 |
Why?
|
| Gastrostomy | 5 | 2019 | 189 | 0.800 |
Why?
|
| Peritoneal Dialysis | 3 | 2018 | 126 | 0.800 |
Why?
|
| Hospitals, Pediatric | 9 | 2022 | 793 | 0.790 |
Why?
|
| Esophageal Diseases | 2 | 2016 | 75 | 0.780 |
Why?
|
| Umbilicus | 2 | 2013 | 16 | 0.780 |
Why?
|
| Computer-Assisted Instruction | 2 | 2012 | 85 | 0.780 |
Why?
|
| Specialties, Surgical | 4 | 2020 | 144 | 0.760 |
Why?
|
| Surgeons | 6 | 2024 | 561 | 0.740 |
Why?
|
| Informed Consent | 4 | 2024 | 435 | 0.740 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 2018 | 74 | 0.710 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 193 | 0.710 |
Why?
|
| Humans | 198 | 2024 | 270969 | 0.710 |
Why?
|
| Child, Preschool | 58 | 2021 | 16882 | 0.680 |
Why?
|
| Lipoblastoma | 3 | 2016 | 7 | 0.680 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2012 | 207 | 0.680 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 2013 | 511 | 0.670 |
Why?
|
| Educational Measurement | 4 | 2015 | 413 | 0.660 |
Why?
|
| Heller Myotomy | 1 | 2019 | 7 | 0.660 |
Why?
|
| Kidney Failure, Chronic | 5 | 2018 | 985 | 0.660 |
Why?
|
| Female | 147 | 2023 | 147624 | 0.660 |
Why?
|
| Biliary Atresia | 7 | 2020 | 198 | 0.660 |
Why?
|
| Manometry | 1 | 2019 | 77 | 0.650 |
Why?
|
| Internet | 3 | 2012 | 741 | 0.650 |
Why?
|
| Colostomy | 1 | 2019 | 79 | 0.640 |
Why?
|
| Parental Consent | 2 | 2018 | 26 | 0.640 |
Why?
|
| Male | 133 | 2023 | 127769 | 0.640 |
Why?
|
| Pediatric Obesity | 7 | 2018 | 374 | 0.630 |
Why?
|
| Job Satisfaction | 3 | 2021 | 131 | 0.620 |
Why?
|
| Weight Loss | 15 | 2023 | 650 | 0.620 |
Why?
|
| Retrospective Studies | 64 | 2022 | 39724 | 0.620 |
Why?
|
| Laparotomy | 5 | 2013 | 216 | 0.610 |
Why?
|
| Postoperative Complications | 26 | 2018 | 5853 | 0.600 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2014 | 213 | 0.600 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2018 | 45 | 0.590 |
Why?
|
| Alagille Syndrome | 1 | 2018 | 46 | 0.590 |
Why?
|
| Quality of Life | 11 | 2022 | 4737 | 0.590 |
Why?
|
| Inguinal Canal | 2 | 2014 | 62 | 0.570 |
Why?
|
| Liver Transplantation | 10 | 2020 | 1169 | 0.560 |
Why?
|
| Adrenal Medulla | 2 | 2013 | 17 | 0.560 |
Why?
|
| Infant, Newborn | 39 | 2021 | 8593 | 0.560 |
Why?
|
| Intestinal Perforation | 5 | 2013 | 105 | 0.550 |
Why?
|
| Intestinal Obstruction | 6 | 2019 | 218 | 0.550 |
Why?
|
| Pediatrics | 8 | 2024 | 1191 | 0.540 |
Why?
|
| Fibroadenoma | 2 | 2013 | 26 | 0.530 |
Why?
|
| Peritoneum | 3 | 2016 | 156 | 0.530 |
Why?
|
| Health Education | 1 | 2018 | 315 | 0.530 |
Why?
|
| Students, Medical | 4 | 2015 | 434 | 0.530 |
Why?
|
| Internship and Residency | 7 | 2024 | 1486 | 0.520 |
Why?
|
| Intubation, Gastrointestinal | 3 | 2019 | 87 | 0.520 |
Why?
|
| Health Resources | 2 | 2014 | 172 | 0.510 |
Why?
|
| Pylorus | 3 | 2008 | 28 | 0.500 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 769 | 0.490 |
Why?
|
| Software | 2 | 2012 | 1342 | 0.490 |
Why?
|
| Preoperative Care | 5 | 2019 | 1556 | 0.490 |
Why?
|
| Intestine, Small | 5 | 2019 | 513 | 0.490 |
Why?
|
| Breast Diseases | 2 | 2006 | 205 | 0.480 |
Why?
|
| Enteral Nutrition | 5 | 2019 | 337 | 0.480 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 959 | 0.480 |
Why?
|
| Breast | 3 | 2013 | 1361 | 0.480 |
Why?
|
| Cysts | 2 | 2013 | 202 | 0.470 |
Why?
|
| Snake Bites | 1 | 2014 | 8 | 0.470 |
Why?
|
| Antivenins | 1 | 2014 | 9 | 0.470 |
Why?
|
| Social Welfare | 1 | 2013 | 6 | 0.470 |
Why?
|
| Ovarian Cysts | 3 | 2014 | 42 | 0.460 |
Why?
|
| Curriculum | 5 | 2015 | 916 | 0.460 |
Why?
|
| Volunteers | 1 | 2013 | 31 | 0.460 |
Why?
|
| Ovary | 2 | 2016 | 686 | 0.460 |
Why?
|
| Pilomatrixoma | 1 | 2013 | 9 | 0.450 |
Why?
|
| Adrenal Insufficiency | 1 | 2014 | 50 | 0.450 |
Why?
|
| Hair Diseases | 1 | 2013 | 42 | 0.440 |
Why?
|
| Catheterization | 1 | 2016 | 436 | 0.440 |
Why?
|
| Hemangioendothelioma | 1 | 2013 | 34 | 0.440 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2013 | 38 | 0.440 |
Why?
|
| Critical Care | 2 | 2011 | 796 | 0.430 |
Why?
|
| Portoenterostomy, Hepatic | 4 | 2020 | 49 | 0.430 |
Why?
|
| Esophagogastric Junction | 1 | 2016 | 559 | 0.430 |
Why?
|
| Puberty, Precocious | 2 | 2012 | 30 | 0.420 |
Why?
|
| Body Mass Index | 16 | 2020 | 2281 | 0.420 |
Why?
|
| Duodenum | 2 | 2013 | 155 | 0.410 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2013 | 122 | 0.410 |
Why?
|
| Drug Implants | 1 | 2012 | 49 | 0.400 |
Why?
|
| Liver Diseases | 5 | 2013 | 597 | 0.400 |
Why?
|
| Cicatrix | 1 | 2013 | 206 | 0.400 |
Why?
|
| Surgical Procedures, Operative | 3 | 2016 | 378 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2020 | 1424 | 0.390 |
Why?
|
| Child Development | 1 | 2013 | 265 | 0.380 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2012 | 168 | 0.380 |
Why?
|
| Histocytochemistry | 1 | 2011 | 186 | 0.370 |
Why?
|
| Pheochromocytoma | 2 | 2013 | 297 | 0.370 |
Why?
|
| Education, Medical, Graduate | 4 | 2024 | 716 | 0.350 |
Why?
|
| Burkitt Lymphoma | 1 | 2013 | 344 | 0.350 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2012 | 294 | 0.350 |
Why?
|
| Fungi | 1 | 2011 | 147 | 0.340 |
Why?
|
| Intensive Care Units | 2 | 2020 | 748 | 0.330 |
Why?
|
| Gastroplasty | 3 | 2020 | 23 | 0.330 |
Why?
|
| Teaching | 2 | 2012 | 252 | 0.320 |
Why?
|
| Follow-Up Studies | 20 | 2020 | 15255 | 0.320 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2008 | 7 | 0.320 |
Why?
|
| Gastroesophageal Reflux | 5 | 2019 | 351 | 0.320 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2013 | 882 | 0.310 |
Why?
|
| Neonatal Screening | 3 | 2020 | 183 | 0.310 |
Why?
|
| Bilirubin | 3 | 2020 | 223 | 0.310 |
Why?
|
| Mediastinal Cyst | 1 | 2008 | 22 | 0.310 |
Why?
|
| Surveys and Questionnaires | 13 | 2024 | 5952 | 0.310 |
Why?
|
| Sepsis | 4 | 2015 | 668 | 0.310 |
Why?
|
| Disease Management | 1 | 2014 | 1118 | 0.300 |
Why?
|
| Ultrasonography | 8 | 2021 | 1928 | 0.300 |
Why?
|
| Hyperbilirubinemia | 1 | 2008 | 78 | 0.300 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 435 | 0.300 |
Why?
|
| Radiography, Abdominal | 3 | 2019 | 121 | 0.300 |
Why?
|
| Anus, Imperforate | 1 | 2007 | 12 | 0.300 |
Why?
|
| Treatment Outcome | 32 | 2020 | 34335 | 0.290 |
Why?
|
| Mycoses | 1 | 2011 | 388 | 0.290 |
Why?
|
| Competency-Based Education | 1 | 2008 | 83 | 0.290 |
Why?
|
| Abdomen | 3 | 2015 | 338 | 0.280 |
Why?
|
| Risk Factors | 21 | 2018 | 18036 | 0.280 |
Why?
|
| Fecal Incontinence | 1 | 2007 | 89 | 0.280 |
Why?
|
| Young Adult | 22 | 2022 | 22268 | 0.280 |
Why?
|
| Body Weight | 3 | 2016 | 1324 | 0.270 |
Why?
|
| Patient Care Team | 2 | 2013 | 829 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 5 | 2014 | 3119 | 0.270 |
Why?
|
| Infant, Premature, Diseases | 6 | 2014 | 257 | 0.270 |
Why?
|
| Workload | 2 | 2013 | 204 | 0.270 |
Why?
|
| Hernia, Obturator | 1 | 2005 | 5 | 0.270 |
Why?
|
| Diagnosis, Differential | 12 | 2019 | 4867 | 0.260 |
Why?
|
| Cell Transplantation | 2 | 1996 | 81 | 0.260 |
Why?
|
| Academic Medical Centers | 2 | 2013 | 697 | 0.260 |
Why?
|
| Fibrinogen | 3 | 2015 | 208 | 0.250 |
Why?
|
| Abscess | 1 | 2006 | 179 | 0.250 |
Why?
|
| Insurance Coverage | 2 | 2020 | 273 | 0.250 |
Why?
|
| Time Factors | 15 | 2020 | 13261 | 0.240 |
Why?
|
| Severity of Illness Index | 8 | 2019 | 4462 | 0.240 |
Why?
|
| United States | 20 | 2024 | 16325 | 0.240 |
Why?
|
| Fetus | 2 | 1999 | 625 | 0.240 |
Why?
|
| Reference Values | 4 | 2020 | 1127 | 0.240 |
Why?
|
| Renal Insufficiency | 1 | 2007 | 327 | 0.240 |
Why?
|
| Incidence | 13 | 2020 | 5893 | 0.230 |
Why?
|
| Prospective Studies | 20 | 2023 | 13336 | 0.230 |
Why?
|
| Empyema, Pleural | 1 | 2004 | 50 | 0.230 |
Why?
|
| Staphylococcal Infections | 2 | 2004 | 680 | 0.230 |
Why?
|
| Obesity | 9 | 2014 | 2983 | 0.230 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2015 | 178 | 0.230 |
Why?
|
| Prenatal Diagnosis | 3 | 2018 | 608 | 0.220 |
Why?
|
| Age Factors | 10 | 2020 | 5498 | 0.220 |
Why?
|
| Length of Stay | 9 | 2020 | 2048 | 0.210 |
Why?
|
| Reoperation | 7 | 2019 | 1455 | 0.210 |
Why?
|
| Peer Group | 1 | 2024 | 133 | 0.210 |
Why?
|
| Logistic Models | 8 | 2018 | 3487 | 0.210 |
Why?
|
| Sensitivity and Specificity | 14 | 2021 | 5121 | 0.210 |
Why?
|
| Intestinal Diseases | 2 | 2011 | 126 | 0.210 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2002 | 11 | 0.200 |
Why?
|
| Clinical Competence | 3 | 2016 | 1368 | 0.200 |
Why?
|
| Critical Pathways | 2 | 2013 | 160 | 0.200 |
Why?
|
| Parovarian Cyst | 2 | 2011 | 14 | 0.200 |
Why?
|
| Pneumococcal Infections | 1 | 2004 | 273 | 0.200 |
Why?
|
| Feeding and Eating Disorders | 2 | 2019 | 94 | 0.200 |
Why?
|
| Cholecystectomy | 2 | 2011 | 116 | 0.190 |
Why?
|
| Compassion Fatigue | 1 | 2021 | 4 | 0.190 |
Why?
|
| Drainage | 3 | 2006 | 431 | 0.190 |
Why?
|
| Lipomatosis | 1 | 2001 | 23 | 0.190 |
Why?
|
| Hospital Mortality | 1 | 2007 | 1403 | 0.190 |
Why?
|
| Intestinal Volvulus | 1 | 2021 | 37 | 0.190 |
Why?
|
| Digestive System Abnormalities | 1 | 2021 | 41 | 0.180 |
Why?
|
| Acute Disease | 7 | 2018 | 2489 | 0.180 |
Why?
|
| Endoscopy | 2 | 2016 | 498 | 0.180 |
Why?
|
| Choledocholithiasis | 1 | 2020 | 22 | 0.180 |
Why?
|
| Lipoma | 1 | 2001 | 88 | 0.180 |
Why?
|
| Cholelithiasis | 1 | 2000 | 47 | 0.180 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2013 | 912 | 0.180 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2004 | 184 | 0.180 |
Why?
|
| Risk Assessment | 8 | 2020 | 7105 | 0.180 |
Why?
|
| Cardiovascular Diseases | 4 | 2018 | 2287 | 0.180 |
Why?
|
| Texas | 8 | 2014 | 6489 | 0.170 |
Why?
|
| Authorship | 1 | 2020 | 54 | 0.170 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2020 | 77 | 0.170 |
Why?
|
| Sexism | 1 | 2020 | 60 | 0.170 |
Why?
|
| Ileostomy | 1 | 2000 | 45 | 0.170 |
Why?
|
| Pyloric Stenosis | 1 | 1999 | 10 | 0.170 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 59 | 0.170 |
Why?
|
| beta-Galactosidase | 1 | 1999 | 223 | 0.170 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 311 | 0.170 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2020 | 66 | 0.170 |
Why?
|
| Radiography | 4 | 2014 | 1936 | 0.170 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 876 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2019 | 63 | 0.170 |
Why?
|
| Trauma Centers | 1 | 2020 | 177 | 0.160 |
Why?
|
| Anorectal Malformations | 1 | 2019 | 12 | 0.160 |
Why?
|
| Feeding Methods | 1 | 1999 | 38 | 0.160 |
Why?
|
| Problem-Based Learning | 2 | 2012 | 81 | 0.160 |
Why?
|
| Adult | 30 | 2022 | 80872 | 0.160 |
Why?
|
| Chemoprevention | 1 | 2020 | 250 | 0.160 |
Why?
|
| Thyroidectomy | 3 | 2017 | 495 | 0.160 |
Why?
|
| Gastrectomy | 3 | 2019 | 480 | 0.160 |
Why?
|
| Incidental Findings | 2 | 2013 | 285 | 0.160 |
Why?
|
| Liver | 8 | 2015 | 2993 | 0.160 |
Why?
|
| Time Management | 1 | 2018 | 16 | 0.160 |
Why?
|
| Urinary Incontinence | 2 | 2017 | 151 | 0.160 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2018 | 33 | 0.160 |
Why?
|
| CD40 Antigens | 1 | 2019 | 109 | 0.150 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 2048 | 0.150 |
Why?
|
| Infant, Premature | 7 | 2014 | 831 | 0.150 |
Why?
|
| Intestines | 3 | 2014 | 690 | 0.150 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 95 | 0.150 |
Why?
|
| Visceral Prolapse | 1 | 2017 | 2 | 0.150 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 157 | 0.150 |
Why?
|
| Accidents, Occupational | 1 | 2017 | 12 | 0.150 |
Why?
|
| Comprehension | 1 | 2018 | 125 | 0.150 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 16073 | 0.150 |
Why?
|
| Enterohepatic Circulation | 1 | 2017 | 11 | 0.150 |
Why?
|
| Postoperative Care | 2 | 1999 | 751 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 1999 | 725 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 274 | 0.140 |
Why?
|
| Educational Status | 1 | 2018 | 404 | 0.140 |
Why?
|
| Anesthesia | 1 | 2020 | 293 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2018 | 310 | 0.140 |
Why?
|
| Wounds and Injuries | 2 | 2020 | 428 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 149 | 0.140 |
Why?
|
| Anesthesia, General | 1 | 2018 | 230 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 4744 | 0.140 |
Why?
|
| Leadership | 2 | 2011 | 275 | 0.140 |
Why?
|
| Hypocalcemia | 1 | 2017 | 59 | 0.140 |
Why?
|
| Predictive Value of Tests | 9 | 2020 | 5015 | 0.140 |
Why?
|
| Transplantation, Heterotopic | 1 | 1996 | 42 | 0.140 |
Why?
|
| Portal System | 1 | 1996 | 38 | 0.140 |
Why?
|
| Needles | 1 | 1997 | 107 | 0.140 |
Why?
|
| Career Mobility | 1 | 2017 | 97 | 0.140 |
Why?
|
| Pyriform Sinus | 1 | 2016 | 9 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 323 | 0.130 |
Why?
|
| Health Care Costs | 2 | 2012 | 718 | 0.130 |
Why?
|
| Occupational Diseases | 1 | 2017 | 134 | 0.130 |
Why?
|
| Middle Aged | 16 | 2020 | 89661 | 0.130 |
Why?
|
| Diseases in Twins | 2 | 2013 | 99 | 0.130 |
Why?
|
| Kidney | 3 | 2014 | 2201 | 0.130 |
Why?
|
| Twins, Monozygotic | 2 | 2013 | 130 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2016 | 10282 | 0.130 |
Why?
|
| Jejunostomy | 2 | 2017 | 54 | 0.130 |
Why?
|
| Factor XIII | 1 | 2015 | 8 | 0.130 |
Why?
|
| Quality Improvement | 2 | 2014 | 929 | 0.130 |
Why?
|
| Pneumothorax | 2 | 2014 | 162 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2022 | 828 | 0.130 |
Why?
|
| Odds Ratio | 5 | 2017 | 2302 | 0.130 |
Why?
|
| Gastric Mucosa | 2 | 2017 | 624 | 0.130 |
Why?
|
| Meckel Diverticulum | 2 | 2013 | 12 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 7765 | 0.130 |
Why?
|
| Intussusception | 2 | 2013 | 53 | 0.130 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 87 | 0.130 |
Why?
|
| Thoracostomy | 2 | 2014 | 46 | 0.130 |
Why?
|
| Fistula | 1 | 2016 | 79 | 0.130 |
Why?
|
| Career Choice | 1 | 2017 | 235 | 0.130 |
Why?
|
| Eating | 1 | 2017 | 438 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 368 | 0.130 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 54 | 0.120 |
Why?
|
| Certification | 1 | 2016 | 127 | 0.120 |
Why?
|
| Musculoskeletal Pain | 1 | 2015 | 26 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 4357 | 0.120 |
Why?
|
| Health Care Surveys | 2 | 2013 | 445 | 0.120 |
Why?
|
| Y Chromosome | 1 | 1995 | 75 | 0.120 |
Why?
|
| Gastrointestinal Hormones | 2 | 2015 | 25 | 0.120 |
Why?
|
| Empathy | 2 | 2021 | 109 | 0.120 |
Why?
|
| Wounds, Penetrating | 3 | 1993 | 93 | 0.120 |
Why?
|
| Confidence Intervals | 3 | 2017 | 760 | 0.120 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2014 | 24 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 285 | 0.120 |
Why?
|
| Splanchnic Circulation | 1 | 2014 | 59 | 0.120 |
Why?
|
| Cryptococcosis | 2 | 2006 | 64 | 0.120 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2008 | 117 | 0.120 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1995 | 78 | 0.120 |
Why?
|
| Thyroid Gland | 2 | 2013 | 360 | 0.120 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2008 | 173 | 0.120 |
Why?
|
| Choristoma | 2 | 2011 | 84 | 0.120 |
Why?
|
| Biomarkers | 6 | 2016 | 5161 | 0.120 |
Why?
|
| Pleurodesis | 1 | 2014 | 71 | 0.120 |
Why?
|
| Prevalence | 5 | 2015 | 3399 | 0.120 |
Why?
|
| Anticoagulants | 1 | 2020 | 848 | 0.120 |
Why?
|
| Escherichia coli Infections | 2 | 2013 | 256 | 0.120 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 235 | 0.120 |
Why?
|
| Organ Sparing Treatments | 1 | 2016 | 280 | 0.120 |
Why?
|
| Caregivers | 2 | 2013 | 730 | 0.120 |
Why?
|
| Bariatric Medicine | 1 | 2013 | 1 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2006 | 163 | 0.120 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2011 | 77 | 0.110 |
Why?
|
| Enema | 2 | 2013 | 48 | 0.110 |
Why?
|
| Algorithms | 3 | 2014 | 3980 | 0.110 |
Why?
|
| Blood Glucose | 3 | 2018 | 1280 | 0.110 |
Why?
|
| Liver Abscess | 1 | 1994 | 37 | 0.110 |
Why?
|
| Esophageal Atresia | 1 | 2014 | 49 | 0.110 |
Why?
|
| Thyroid Neoplasms | 2 | 2013 | 1900 | 0.110 |
Why?
|
| Stomach | 1 | 1997 | 393 | 0.110 |
Why?
|
| Adolescent Health Services | 1 | 2013 | 40 | 0.110 |
Why?
|
| Spleen | 1 | 1996 | 698 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2014 | 102 | 0.110 |
Why?
|
| Gestational Age | 5 | 2018 | 1109 | 0.110 |
Why?
|
| Emergency Service, Hospital | 2 | 2019 | 1222 | 0.110 |
Why?
|
| Pleural Diseases | 1 | 1994 | 58 | 0.110 |
Why?
|
| Bezoars | 1 | 2013 | 7 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2017 | 327 | 0.110 |
Why?
|
| Psychology, Child | 1 | 2013 | 45 | 0.110 |
Why?
|
| Medical Errors | 3 | 2024 | 223 | 0.110 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2014 | 127 | 0.110 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 4552 | 0.110 |
Why?
|
| Uterus | 2 | 2014 | 703 | 0.110 |
Why?
|
| Chest Tubes | 1 | 1994 | 119 | 0.110 |
Why?
|
| Meningitis, Fungal | 1 | 2012 | 7 | 0.110 |
Why?
|
| Personal Satisfaction | 3 | 2021 | 132 | 0.110 |
Why?
|
| Candidiasis | 2 | 2004 | 271 | 0.110 |
Why?
|
| Trichotillomania | 1 | 2013 | 34 | 0.110 |
Why?
|
| Awareness | 1 | 2013 | 125 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 365 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2011 | 1060 | 0.110 |
Why?
|
| Drug Contamination | 1 | 2012 | 49 | 0.110 |
Why?
|
| Cohort Studies | 9 | 2019 | 9466 | 0.110 |
Why?
|
| Patient Handoff | 1 | 2013 | 42 | 0.110 |
Why?
|
| Parents | 1 | 2020 | 1060 | 0.110 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 590 | 0.100 |
Why?
|
| Schools, Medical | 1 | 2013 | 140 | 0.100 |
Why?
|
| Genetic Therapy | 2 | 1999 | 1631 | 0.100 |
Why?
|
| Meconium | 2 | 2004 | 7 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 1168 | 0.100 |
Why?
|
| Disease Susceptibility | 3 | 2011 | 533 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 131 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 7982 | 0.100 |
Why?
|
| Methylprednisolone | 1 | 2012 | 189 | 0.100 |
Why?
|
| End Stage Liver Disease | 1 | 2014 | 186 | 0.100 |
Why?
|
| Short Bowel Syndrome | 2 | 2010 | 63 | 0.100 |
Why?
|
| Antifungal Agents | 3 | 2012 | 859 | 0.100 |
Why?
|
| Disaster Planning | 1 | 2012 | 67 | 0.100 |
Why?
|
| Suture Techniques | 2 | 2013 | 316 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 175 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 78 | 0.100 |
Why?
|
| Hyperandrogenism | 1 | 2011 | 20 | 0.100 |
Why?
|
| Gallbladder Diseases | 1 | 2011 | 46 | 0.100 |
Why?
|
| Administration, Cutaneous | 1 | 2012 | 143 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2016 | 30845 | 0.100 |
Why?
|
| Splenectomy | 1 | 2012 | 167 | 0.100 |
Why?
|
| Disorders of Sex Development | 1 | 2012 | 86 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2016 | 2304 | 0.100 |
Why?
|
| Siblings | 1 | 2013 | 294 | 0.100 |
Why?
|
| Chronic Pain | 1 | 2015 | 263 | 0.100 |
Why?
|
| Stomach Diseases | 1 | 2011 | 65 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 1663 | 0.090 |
Why?
|
| Motor Activity | 1 | 2015 | 690 | 0.090 |
Why?
|
| Platelet Count | 3 | 2012 | 495 | 0.090 |
Why?
|
| Comorbidity | 6 | 2016 | 2447 | 0.090 |
Why?
|
| Ligation | 3 | 2008 | 192 | 0.090 |
Why?
|
| Sex Factors | 3 | 2018 | 2198 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 3218 | 0.090 |
Why?
|
| Emergency Medicine | 1 | 2012 | 146 | 0.090 |
Why?
|
| Fetal Diseases | 2 | 1992 | 413 | 0.090 |
Why?
|
| Pregnancy | 8 | 2018 | 7898 | 0.090 |
Why?
|
| Diaphragm | 1 | 1992 | 186 | 0.090 |
Why?
|
| Age Distribution | 3 | 2015 | 712 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 3 | 2008 | 184 | 0.090 |
Why?
|
| Prognosis | 9 | 2023 | 22348 | 0.090 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 1990 | 72 | 0.090 |
Why?
|
| Michigan | 2 | 2007 | 71 | 0.090 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 127 | 0.090 |
Why?
|
| Catheter Ablation | 1 | 2016 | 667 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 428 | 0.090 |
Why?
|
| Oxygen | 1 | 2014 | 782 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 1035 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2010 | 142 | 0.090 |
Why?
|
| Down Syndrome | 1 | 2013 | 229 | 0.090 |
Why?
|
| Ovarian Neoplasms | 3 | 2016 | 4720 | 0.090 |
Why?
|
| Herniorrhaphy | 1 | 2011 | 184 | 0.090 |
Why?
|
| Parenteral Nutrition | 1 | 2011 | 213 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2010 | 241 | 0.080 |
Why?
|
| Alanine Transaminase | 2 | 2023 | 240 | 0.080 |
Why?
|
| Interpersonal Relations | 2 | 2008 | 282 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 197 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 637 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2011 | 181 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 4 | 2013 | 2487 | 0.080 |
Why?
|
| Aged | 12 | 2017 | 73018 | 0.080 |
Why?
|
| Granulosa Cell Tumor | 1 | 2009 | 81 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2015 | 1012 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 1125 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2012 | 631 | 0.080 |
Why?
|
| Rabbits | 3 | 1999 | 979 | 0.080 |
Why?
|
| Subcutaneous Tissue | 1 | 2008 | 63 | 0.080 |
Why?
|
| Renal Dialysis | 2 | 2008 | 970 | 0.080 |
Why?
|
| Creatinine | 2 | 2008 | 553 | 0.080 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 123 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2010 | 254 | 0.080 |
Why?
|
| Pancreas | 2 | 2011 | 734 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 2010 | 242 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 818 | 0.080 |
Why?
|
| Sternum | 1 | 2008 | 102 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2013 | 720 | 0.080 |
Why?
|
| Enuresis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 653 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 416 | 0.070 |
Why?
|
| Social Change | 1 | 2007 | 16 | 0.070 |
Why?
|
| Models, Educational | 1 | 2008 | 96 | 0.070 |
Why?
|
| Pain Management | 1 | 2013 | 713 | 0.070 |
Why?
|
| Peptides | 1 | 2013 | 1504 | 0.070 |
Why?
|
| Ganglion Cysts | 1 | 2007 | 5 | 0.070 |
Why?
|
| Temporomandibular Joint | 1 | 2007 | 24 | 0.070 |
Why?
|
| Syndrome | 2 | 2013 | 1377 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1930 | 0.070 |
Why?
|
| Accreditation | 1 | 2008 | 138 | 0.070 |
Why?
|
| Consensus | 1 | 2012 | 1104 | 0.070 |
Why?
|
| Wrist Joint | 1 | 2007 | 30 | 0.070 |
Why?
|
| HIV Seroprevalence | 1 | 2006 | 11 | 0.070 |
Why?
|
| Ankle Joint | 1 | 2007 | 38 | 0.070 |
Why?
|
| Pancreatectomy | 1 | 2011 | 683 | 0.070 |
Why?
|
| Gallstones | 2 | 2011 | 63 | 0.070 |
Why?
|
| ROC Curve | 3 | 2015 | 1213 | 0.070 |
Why?
|
| Population Surveillance | 3 | 2006 | 642 | 0.070 |
Why?
|
| Motivation | 1 | 2010 | 523 | 0.070 |
Why?
|
| Abdominal Pain | 3 | 2005 | 376 | 0.070 |
Why?
|
| Disease Progression | 1 | 2018 | 6881 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 533 | 0.070 |
Why?
|
| Remission Induction | 2 | 2019 | 3622 | 0.070 |
Why?
|
| Duodenal Diseases | 2 | 1986 | 44 | 0.070 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 140 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2024 | 624 | 0.070 |
Why?
|
| Decision Making | 1 | 2014 | 1341 | 0.070 |
Why?
|
| Professional Competence | 1 | 2007 | 140 | 0.070 |
Why?
|
| Leukocyte Count | 2 | 2005 | 707 | 0.070 |
Why?
|
| Rupture, Spontaneous | 1 | 2005 | 71 | 0.070 |
Why?
|
| Anxiety | 1 | 2013 | 1251 | 0.070 |
Why?
|
| Immunocompromised Host | 2 | 2012 | 711 | 0.070 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2008 | 406 | 0.060 |
Why?
|
| Self Concept | 1 | 2007 | 203 | 0.060 |
Why?
|
| Triglycerides | 2 | 2023 | 617 | 0.060 |
Why?
|
| Malabsorption Syndromes | 1 | 1985 | 55 | 0.060 |
Why?
|
| Postoperative Period | 2 | 2017 | 672 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2011 | 9311 | 0.060 |
Why?
|
| Genetic Vectors | 4 | 1999 | 1718 | 0.060 |
Why?
|
| Paraganglioma | 1 | 2007 | 183 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 2 | 2008 | 668 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2002 | 1398 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2008 | 364 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 7711 | 0.060 |
Why?
|
| Ovariectomy | 2 | 2009 | 336 | 0.060 |
Why?
|
| Histamine H2 Antagonists | 1 | 2005 | 51 | 0.060 |
Why?
|
| Cause of Death | 1 | 2008 | 791 | 0.060 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 319 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 1355 | 0.060 |
Why?
|
| Platelet Transfusion | 1 | 2005 | 162 | 0.060 |
Why?
|
| Peptic Ulcer | 1 | 2005 | 144 | 0.060 |
Why?
|
| Thoracic Arteries | 1 | 2004 | 10 | 0.060 |
Why?
|
| Pulmonary Surfactants | 1 | 2004 | 49 | 0.060 |
Why?
|
| Fungemia | 1 | 2004 | 116 | 0.060 |
Why?
|
| Combined Modality Therapy | 4 | 2012 | 9020 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2004 | 66 | 0.060 |
Why?
|
| Genetic Markers | 2 | 1999 | 921 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 3096 | 0.050 |
Why?
|
| North America | 1 | 2004 | 337 | 0.050 |
Why?
|
| Disclosure | 1 | 2024 | 188 | 0.050 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 552 | 0.050 |
Why?
|
| Family | 1 | 2007 | 745 | 0.050 |
Why?
|
| Peritonitis | 3 | 2013 | 91 | 0.050 |
Why?
|
| Elective Surgical Procedures | 2 | 2005 | 264 | 0.050 |
Why?
|
| Area Under Curve | 2 | 2015 | 718 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2010 | 915 | 0.050 |
Why?
|
| Candida | 1 | 2004 | 168 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2024 | 1406 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 6181 | 0.050 |
Why?
|
| Physician's Role | 1 | 2024 | 246 | 0.050 |
Why?
|
| Diarrhea | 1 | 1985 | 697 | 0.050 |
Why?
|
| Menarche | 2 | 2011 | 50 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 7456 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 1 | 2004 | 360 | 0.050 |
Why?
|
| Exercise | 1 | 2009 | 1217 | 0.050 |
Why?
|
| Diet | 1 | 2009 | 1472 | 0.050 |
Why?
|
| Ovarian Diseases | 2 | 2011 | 53 | 0.050 |
Why?
|
| Linear Models | 2 | 2019 | 1092 | 0.050 |
Why?
|
| Torsion Abnormality | 2 | 2011 | 39 | 0.050 |
Why?
|
| Adnexal Diseases | 2 | 2011 | 31 | 0.050 |
Why?
|
| Hypertension | 3 | 2019 | 1576 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2011 | 111 | 0.050 |
Why?
|
| Hospitals, Teaching | 2 | 2011 | 124 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 423 | 0.050 |
Why?
|
| Abdominal Wall | 1 | 2004 | 187 | 0.050 |
Why?
|
| Animals | 11 | 2019 | 61175 | 0.050 |
Why?
|
| Data Collection | 1 | 2004 | 642 | 0.050 |
Why?
|
| Neutrophils | 1 | 2005 | 850 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 2018 | 937 | 0.050 |
Why?
|
| Communication | 1 | 2007 | 912 | 0.050 |
Why?
|
| Social Support | 1 | 2024 | 575 | 0.050 |
Why?
|
| Canada | 2 | 2020 | 438 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 795 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2015 | 1004 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 560 | 0.040 |
Why?
|
| DNA, Recombinant | 1 | 1999 | 119 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2020 | 76 | 0.040 |
Why?
|
| Surgical Wound Infection | 2 | 2013 | 471 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2019 | 91 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 175 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 1999 | 83 | 0.040 |
Why?
|
| Pneumoperitoneum | 2 | 2005 | 17 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 55 | 0.040 |
Why?
|
| Constipation | 1 | 2000 | 181 | 0.040 |
Why?
|
| Pharynx | 1 | 1999 | 152 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 99 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2002 | 345 | 0.040 |
Why?
|
| Hypertrophy | 1 | 1999 | 164 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 2 | 2019 | 980 | 0.040 |
Why?
|
| Ferritins | 1 | 2019 | 153 | 0.040 |
Why?
|
| Emergencies | 1 | 2000 | 205 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2015 | 1290 | 0.040 |
Why?
|
| Biopsy | 3 | 2015 | 3502 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2024 | 810 | 0.040 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 1977 | 0.040 |
Why?
|
| Databases, Factual | 3 | 2016 | 2314 | 0.040 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 119 | 0.040 |
Why?
|
| Urinary Tract | 1 | 2018 | 80 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 2017 | 21 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6269 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 1272 | 0.040 |
Why?
|
| Adenoviridae | 2 | 1999 | 1458 | 0.040 |
Why?
|
| Anthropometry | 1 | 2018 | 270 | 0.040 |
Why?
|
| Pain | 1 | 1985 | 1689 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 1999 | 1348 | 0.040 |
Why?
|
| Barium | 1 | 1997 | 26 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2013 | 370 | 0.040 |
Why?
|
| Vitamin D | 1 | 2019 | 265 | 0.040 |
Why?
|
| Professional Practice Location | 1 | 2016 | 14 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 7130 | 0.030 |
Why?
|
| Health Status | 1 | 2020 | 610 | 0.030 |
Why?
|
| Renal Veins | 1 | 1996 | 57 | 0.030 |
Why?
|
| Urban Health Services | 1 | 2016 | 35 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 909 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2017 | 202 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2000 | 358 | 0.030 |
Why?
|
| Vulva | 1 | 2016 | 39 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 414 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2016 | 38 | 0.030 |
Why?
|
| Birth Weight | 2 | 2010 | 373 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2013 | 530 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 505 | 0.030 |
Why?
|
| Leukocytosis | 1 | 1996 | 116 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 230 | 0.030 |
Why?
|
| Cholesterol | 1 | 1999 | 677 | 0.030 |
Why?
|
| Antigens, CD19 | 1 | 2019 | 590 | 0.030 |
Why?
|
| Necrosis | 1 | 2017 | 598 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2012 | 562 | 0.030 |
Why?
|
| Injections | 1 | 1996 | 288 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 20 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 2015 | 41 | 0.030 |
Why?
|
| Endodermal Sinus Tumor | 1 | 1995 | 49 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 658 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 16327 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 244 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 272 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 313 | 0.030 |
Why?
|
| Basal Metabolism | 1 | 2015 | 89 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 574 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 219 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2019 | 600 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2015 | 81 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2015 | 125 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 100 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 5094 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 1509 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2014 | 6034 | 0.030 |
Why?
|
| Wound Infection | 2 | 2012 | 56 | 0.030 |
Why?
|
| Thrombosis | 2 | 2002 | 808 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2015 | 1521 | 0.030 |
Why?
|
| Xanthomonas | 1 | 1994 | 3 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2014 | 9 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2014 | 17 | 0.030 |
Why?
|
| Malassezia | 1 | 1994 | 7 | 0.030 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2014 | 72 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 133 | 0.030 |
Why?
|
| Albuminuria | 1 | 2014 | 114 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2012 | 1866 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2014 | 196 | 0.030 |
Why?
|
| Hemothorax | 1 | 1994 | 20 | 0.030 |
Why?
|
| Ischemia | 1 | 2017 | 402 | 0.030 |
Why?
|
| Metformin | 1 | 2018 | 391 | 0.030 |
Why?
|
| Life Style | 1 | 2017 | 619 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 1699 | 0.030 |
Why?
|
| Angiography | 2 | 1993 | 363 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2014 | 88 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 570 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 659 | 0.030 |
Why?
|
| Video Games | 1 | 2015 | 91 | 0.030 |
Why?
|
| Cystatin C | 1 | 2014 | 59 | 0.030 |
Why?
|
| Serpins | 1 | 2014 | 76 | 0.030 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2013 | 9 | 0.030 |
Why?
|
| Hospital Bed Capacity | 1 | 2013 | 29 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 108 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 608 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 1173 | 0.030 |
Why?
|
| Jejunal Neoplasms | 1 | 2013 | 34 | 0.030 |
Why?
|
| Abdominal Abscess | 1 | 2013 | 30 | 0.030 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2013 | 62 | 0.030 |
Why?
|
| Hydrocodone | 1 | 2013 | 52 | 0.030 |
Why?
|
| Risk | 1 | 1997 | 1942 | 0.030 |
Why?
|
| Infectious Disease Incubation Period | 1 | 2012 | 8 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2014 | 236 | 0.030 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2013 | 46 | 0.030 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 69 | 0.030 |
Why?
|
| Leptin | 1 | 2015 | 307 | 0.030 |
Why?
|
| Teratoma | 1 | 1995 | 246 | 0.030 |
Why?
|
| Probability | 2 | 2008 | 876 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2015 | 317 | 0.030 |
Why?
|
| Drug Compounding | 1 | 2012 | 72 | 0.030 |
Why?
|
| Ascomycota | 1 | 2012 | 32 | 0.030 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2012 | 15 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 139 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 390 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2015 | 244 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 93 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 1993 | 63 | 0.030 |
Why?
|
| Malnutrition | 1 | 2015 | 222 | 0.030 |
Why?
|
| Recurrence | 2 | 2014 | 4889 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 363 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2014 | 262 | 0.030 |
Why?
|
| Wounds, Stab | 1 | 1992 | 15 | 0.030 |
Why?
|
| Bites and Stings | 1 | 2012 | 43 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2014 | 275 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2013 | 123 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2012 | 267 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2014 | 277 | 0.030 |
Why?
|
| Focus Groups | 1 | 2013 | 284 | 0.030 |
Why?
|
| Forecasting | 1 | 2015 | 705 | 0.030 |
Why?
|
| Mesenteric Cyst | 1 | 1991 | 4 | 0.030 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2013 | 140 | 0.030 |
Why?
|
| Ectromelia | 1 | 1991 | 6 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 131 | 0.030 |
Why?
|
| Diverticulitis | 1 | 1991 | 5 | 0.030 |
Why?
|
| Aspergillus fumigatus | 1 | 2012 | 139 | 0.030 |
Why?
|
| Hirsutism | 1 | 2011 | 18 | 0.030 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1991 | 17 | 0.030 |
Why?
|
| Isoantibodies | 1 | 2012 | 123 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 564 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 2869 | 0.020 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 1991 | 39 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 158 | 0.020 |
Why?
|
| Body Composition | 1 | 2015 | 612 | 0.020 |
Why?
|
| Patient Transfer | 1 | 2013 | 139 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 1997 | 602 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 1994 | 215 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 2011 | 54 | 0.020 |
Why?
|
| Morphine | 1 | 2013 | 320 | 0.020 |
Why?
|
| Survival Rate | 3 | 2020 | 12475 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1995 | 558 | 0.020 |
Why?
|
| Jaundice | 1 | 2011 | 39 | 0.020 |
Why?
|
| Patient Selection | 2 | 2013 | 2111 | 0.020 |
Why?
|
| Multiple Trauma | 1 | 1992 | 70 | 0.020 |
Why?
|
| Arteries | 1 | 1993 | 283 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 1996 | 965 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 376 | 0.020 |
Why?
|
| Extremities | 1 | 1993 | 310 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 189 | 0.020 |
Why?
|
| Disasters | 1 | 2012 | 106 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 423 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 723 | 0.020 |
Why?
|
| Hemoperitoneum | 1 | 1990 | 12 | 0.020 |
Why?
|
| Rats | 2 | 1999 | 6233 | 0.020 |
Why?
|
| Drug Costs | 1 | 2012 | 149 | 0.020 |
Why?
|
| Symptom Assessment | 1 | 2013 | 275 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 1991 | 47 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 1610 | 0.020 |
Why?
|
| Liposarcoma | 1 | 2013 | 244 | 0.020 |
Why?
|
| Hamartoma | 1 | 1991 | 115 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 1502 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2012 | 247 | 0.020 |
Why?
|
| Premature Birth | 1 | 2015 | 425 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1028 | 0.020 |
Why?
|
| Public Health | 1 | 2012 | 303 | 0.020 |
Why?
|
| Hemangioma | 1 | 1991 | 160 | 0.020 |
Why?
|
| Colonic Diseases | 1 | 1990 | 74 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 800 | 0.020 |
Why?
|
| Adrenarche | 1 | 2009 | 3 | 0.020 |
Why?
|
| Intestinal Neoplasms | 1 | 1991 | 197 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2009 | 11 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2013 | 448 | 0.020 |
Why?
|
| Wound Healing | 1 | 1995 | 829 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 442 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1348 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2013 | 703 | 0.020 |
Why?
|
| Thoracic Surgery | 1 | 1994 | 302 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 654 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2014 | 713 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1475 | 0.020 |
Why?
|
| Visual Fields | 1 | 2010 | 145 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1991 | 352 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2016 | 2393 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2012 | 1433 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2010 | 188 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 1907 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2000 | 1764 | 0.020 |
Why?
|
| Cell Movement | 1 | 1996 | 2510 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2110 | 0.020 |
Why?
|
| Contrast Media | 1 | 2015 | 1497 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 1993 | 445 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 35455 | 0.020 |
Why?
|
| Pancreatitis | 1 | 1990 | 284 | 0.020 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2007 | 33 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 1003 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2008 | 170 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 517 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 2474 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1988 | 221 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 413 | 0.020 |
Why?
|
| South Africa | 1 | 2006 | 97 | 0.020 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2006 | 25 | 0.020 |
Why?
|
| Leg | 1 | 1988 | 234 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 2007 | 194 | 0.020 |
Why?
|
| Fever | 1 | 1990 | 512 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 1995 | 7210 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 581 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 923 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7333 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 368 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2006 | 141 | 0.020 |
Why?
|
| Vagotomy | 1 | 2005 | 26 | 0.020 |
Why?
|
| Peptic Ulcer Perforation | 1 | 2005 | 17 | 0.020 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2005 | 37 | 0.020 |
Why?
|
| Pyloric Antrum | 1 | 2005 | 60 | 0.020 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2005 | 31 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 1178 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 6221 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 1986 | 111 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2008 | 594 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1269 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2013 | 1673 | 0.010 |
Why?
|
| Surface Tension | 1 | 2004 | 6 | 0.010 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2004 | 12 | 0.010 |
Why?
|
| Mental Competency | 1 | 2004 | 61 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 4061 | 0.010 |
Why?
|
| Vomiting | 1 | 1985 | 361 | 0.010 |
Why?
|
| Stroke | 1 | 2012 | 1185 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3660 | 0.010 |
Why?
|
| Drug Resistance, Fungal | 1 | 2004 | 92 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 1437 | 0.010 |
Why?
|
| Nutritional Requirements | 1 | 2004 | 187 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2006 | 512 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 239 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5228 | 0.010 |
Why?
|
| Disease-Free Survival | 2 | 2007 | 10092 | 0.010 |
Why?
|
| Cholestasis | 1 | 2005 | 208 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 952 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 472 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2002 | 124 | 0.010 |
Why?
|
| Echocardiography | 1 | 2008 | 1263 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 12145 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 416 | 0.010 |
Why?
|
| Megacolon | 1 | 2000 | 6 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 1114 | 0.010 |
Why?
|
| Omentum | 1 | 2001 | 97 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2004 | 1031 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 767 | 0.010 |
Why?
|
| Fallopian Tubes | 1 | 2001 | 131 | 0.010 |
Why?
|
| Hirschsprung Disease | 1 | 2000 | 49 | 0.010 |
Why?
|
| Biological Products | 1 | 2004 | 320 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 2934 | 0.010 |
Why?
|
| APOBEC-1 Deaminase | 1 | 1999 | 10 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 1430 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 808 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 389 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2000 | 294 | 0.010 |
Why?
|
| Graft Survival | 2 | 1992 | 1094 | 0.010 |
Why?
|
| Colitis | 1 | 2000 | 338 | 0.010 |
Why?
|
| Thioguanine | 1 | 1996 | 69 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 1999 | 261 | 0.010 |
Why?
|
| Leukapheresis | 1 | 1996 | 162 | 0.010 |
Why?
|
| Atrophy | 1 | 1996 | 268 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1996 | 304 | 0.010 |
Why?
|
| Sacrococcygeal Region | 1 | 1995 | 41 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 262 | 0.010 |
Why?
|
| Autopsy | 1 | 1995 | 180 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1991 | 4793 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1993 | 20 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1992 | 40 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1992 | 118 | 0.010 |
Why?
|
| Sheep | 1 | 1992 | 267 | 0.010 |
Why?
|
| Premedication | 1 | 1991 | 133 | 0.010 |
Why?
|
| Lung Injury | 1 | 1993 | 137 | 0.010 |
Why?
|
| Thoracotomy | 1 | 1993 | 226 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1991 | 16 | 0.010 |
Why?
|
| Causality | 1 | 1991 | 182 | 0.010 |
Why?
|
| Duodenal Obstruction | 1 | 1990 | 10 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1991 | 82 | 0.010 |
Why?
|
| Aging | 1 | 1999 | 1568 | 0.010 |
Why?
|
| Barium Sulfate | 1 | 1990 | 40 | 0.010 |
Why?
|
| Retroviridae | 1 | 1991 | 323 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1992 | 465 | 0.010 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1990 | 18 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1991 | 568 | 0.010 |
Why?
|
| Cytarabine | 1 | 1996 | 1994 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 598 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1992 | 776 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1991 | 477 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1991 | 471 | 0.000 |
Why?
|
| Saphenous Vein | 1 | 1988 | 99 | 0.000 |
Why?
|
| Aneurysm | 1 | 1988 | 97 | 0.000 |
Why?
|
| Jejunal Diseases | 1 | 1986 | 25 | 0.000 |
Why?
|
| Intestinal Fistula | 1 | 1986 | 45 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1992 | 3069 | 0.000 |
Why?
|
| Pancreatic Fistula | 1 | 1986 | 99 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1991 | 2342 | 0.000 |
Why?
|
| Anemia | 1 | 1991 | 740 | 0.000 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1988 | 415 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1991 | 2371 | 0.000 |
Why?
|
| Abnormalities, Multiple | 1 | 1990 | 1010 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1990 | 1093 | 0.000 |
Why?
|
| Transplantation, Autologous | 1 | 1988 | 1977 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1991 | 3838 | 0.000 |
Why?
|